199 related articles for article (PubMed ID: 412210)
1. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.
Linseman MA
Psychopharmacology (Berl); 1977 Oct; 54(2):159-64. PubMed ID: 412210
[TBL] [Abstract][Full Text] [Related]
2. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
Aricioglu-Kartal F; Uzbay IT
Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
[TBL] [Abstract][Full Text] [Related]
4. Persistent effects of the orexin-1 receptor antagonist SB-334867 on naloxone precipitated morphine withdrawal symptoms and nociceptive behaviors in morphine dependent rats.
Kourosh-Arami M; Joghataei MT; Komaki A; Gholami M; Najafi Z; Lavaie M
Int J Neurosci; 2022 Jan; 132(1):67-76. PubMed ID: 32746675
[TBL] [Abstract][Full Text] [Related]
5. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
Fdez Espejo E; Cador M; Stinus L
Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
Ary M; Cox B; Lomax P
J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
[TBL] [Abstract][Full Text] [Related]
7. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine.
Ramabadran K
Life Sci; 1983; 33 Suppl 1():385-8. PubMed ID: 6686634
[TBL] [Abstract][Full Text] [Related]
8. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.
Taylor JR; Lewis VO; Elsworth JD; Pivirotto P; Roth RH; Redmond DE
Psychopharmacology (Berl); 1991; 103(3):407-14. PubMed ID: 2057541
[TBL] [Abstract][Full Text] [Related]
9. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
10. An intraventricular infusion model for inducing morphine dependence in rats: quantitative assessment of precipitated withdrawal.
Huffman RD; Simmons KE; Lum JT
Behav Neurosci; 1985 Oct; 99(5):861-80. PubMed ID: 3843305
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to morphine or naloxone intensifies morphine dependence at maturity.
Koyuncuoğlu H; Aricioğlu F
Pharmacol Biochem Behav; 1993 Apr; 44(4):939-41. PubMed ID: 8469703
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
[TBL] [Abstract][Full Text] [Related]
13. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
[TBL] [Abstract][Full Text] [Related]
14. The effects of different 4-aminopyridine and morphine combinations on the intensity of morphine abstinence.
Koyuncuoğlu H; Nurten A; Enginar N; Ozerman B; Kara I
Pharmacol Res; 2001 Mar; 43(3):245-50. PubMed ID: 11401416
[TBL] [Abstract][Full Text] [Related]
15. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.
Cervo L; Rochat C; Romandini S; Samanin R
Psychopharmacology (Berl); 1981; 74(3):271-4. PubMed ID: 6791237
[TBL] [Abstract][Full Text] [Related]
16. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter.
Maldonado R; Fournié-Zaluski MC; Roques BP
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):466-72. PubMed ID: 1620246
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
Shahidi S; Hasanein P
Brain Res Bull; 2011 Aug; 86(1-2):118-22. PubMed ID: 21763761
[TBL] [Abstract][Full Text] [Related]
19. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
20. Comparative study in mice of flunitrazepam vs. diazepam on morphine withdrawal syndrome.
Gibert-Rahola J; Maldonado R; Micó JA; Leonsegui I; Saavedra MC
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):927-33. PubMed ID: 3241876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
